- Home
- AUPH vs LZB Comparison
AUPH vs LZB Comparison
Compare AUPH & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- LZB
- Stock Information
- Founded
- AUPH 1993
- LZB 1927
- Country
- AUPH Canada
- LZB United States
- Employees
- AUPH N/A
- LZB N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- LZB Home Furnishings
- Sector
- AUPH Health Care
- LZB Consumer Discretionary
- Exchange
- AUPH Nasdaq
- LZB Nasdaq
- Market Cap
- AUPH 1.4B
- LZB 1.6B
- IPO Year
- AUPH 1999
- LZB N/A
- Fundamental
- Price
- AUPH $12.22
- LZB $38.34
- Analyst Decision
- AUPH Strong Buy
- LZB Buy
- Analyst Count
- AUPH 4
- LZB 2
- Target Price
- AUPH $12.25
- LZB $46.00
- AVG Volume (30 Days)
- AUPH 2.8M
- LZB 440.7K
- Earning Date
- AUPH 07-31-2025
- LZB 08-19-2025
- Dividend Yield
- AUPH N/A
- LZB 2.29%
- EPS Growth
- AUPH N/A
- LZB N/A
- EPS
- AUPH 0.42
- LZB 2.35
- Revenue
- AUPH $260,111,000.00
- LZB $2,109,207,000.00
- Revenue This Year
- AUPH $12.15
- LZB $3.69
- Revenue Next Year
- AUPH $18.34
- LZB $3.43
- P/E Ratio
- AUPH $29.06
- LZB $16.31
- Revenue Growth
- AUPH 25.59
- LZB 3.04
- 52 Week Low
- AUPH $6.23
- LZB $34.89
- 52 Week High
- AUPH $12.53
- LZB $48.31
- Technical
- Relative Strength Index (RSI)
- AUPH 78.39
- LZB 53.48
- Support Level
- AUPH $11.18
- LZB $38.13
- Resistance Level
- AUPH $11.69
- LZB $39.08
- Average True Range (ATR)
- AUPH 0.60
- LZB 0.87
- MACD
- AUPH 0.12
- LZB 0.32
- Stochastic Oscillator
- AUPH 91.61
- LZB 75.66
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About LZB La-Z-Boy Incorporated
La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.